ICMR Seeks Partners for Cervical Cancer Drug SHetA2
20 May 2026National
ICMR invited Expressions of Interest for technology transfer and commercialisation of SHetA2, an investigational drug candidate for HPV-induced cervical dysplasia and cervical cancer, with a 20 May applications deadline.
More International Current Affairs
IIT Madras and UNESCO MGIEP Partner to Develop AI-Based Immersive Learning Tools
GK Byte
📅 6 Sept 2026InternationalRead complete →
NIELIT and Intel India Launch Agentic AI Skilling Programmes at National Leadership Dialogue
GK Byte
📅 5 Sept 2026InternationalRead complete →
Tata Elxsi and Sarla Aviation Partner to Develop the 'Shunya' Electric Air Taxi
GK Byte
📅 3 Sept 2026InternationalRead complete →
C-DOT Unveils 14 Indigenous Quantum Products on Its 43rd Foundation Day
GK Byte
📅 2 Sept 2026InternationalRead complete →